BioSpace

U.S. FDA approves expanded indication for Lilly’s Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory ...

Approval is based on results from the BRUIN CLL-321 trial, the only randomized Phase 3 study in CLL/SLL in which all patients were previously treated with a covalent BTK inhibitor This expanded ...
Inside Housing

MPs call for Housing First to be expanded and emergency meeting on temporary accommodation

MPs have called for Housing First to be expanded across the country and for an emergency meeting between councils and housing associations on temporary accommodation amid spiralling costs. MPs have ...
Investing News Network

U.S. FDA approves expanded indication for Lilly's Jaypirca , the first and only non-covalent BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated ...

U.S. FDA approves expanded indication for Lilly's Jaypirca , the first and only non-covalent BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK ...
CoinDesk

GSR Expands Institutional Platform to Raise Transparency, Control in Crypto Trading

Crypto liquidity provider GSR said it expanded its institutional trading and treasury platform, GSR One, to unify market making, systematic OTC trading and treasury management into a single system.